Idiosyncratic Reaction

Classify a rare drug harm as a distinct causal category — dose-independent, qualitatively different in kind, and confined to a small biologically-defined susceptible tail — so it is understood not as too-much-drug but as uniform exposure meeting a heterogeneous responder population.

Core Idea

An idiosyncratic reaction (Type B in the Edwards-Aronson scheme) is a drug effect that strikes a small subset of patients, does not follow the ordinary dose-response curve, and whose mechanism was unpredictable from known pathways. It arises when uniform therapeutic exposure meets a heterogeneous responder population whose small tail — set by a metabolic-enzyme variant, an HLA allele, or a mitochondrial sensitivity — suffers a qualitative, not amplified, deviation.

Scope of Application

The idiosyncratic reaction lives across the safety-evaluation subfields of clinical pharmacology and toxicology — one human-pharmacology substrate; broader rare-tail analogues ride the parent primes, not the clinical label.

• Pharmacogenomics — identifying the responder variant (HLA-B*1502 for carbamazepine) to build a pre-prescription screen.
• Drug-induced liver injury — the prototypical reactive-metabolite-plus-HLA case at 1-in-10,000 incidence.
• Immunopharmacology — hapten-driven anaphylaxis to penicillin, contrast media, and vaccines.
• Anaesthesiology — malignant hyperthermia under volatile anaesthetics in RYR1-variant patients.
• Pharmacovigilance — spontaneous-report signal detection built to catch the trial-invisible tail.

Clarity

The label separates the reaction from three effects it is confused with: a dose-related (Type A) effect, an amplified version of the known pharmacology, and a mere statistical outlier. Its sharpest move is epidemiological: locating the cause in a small tail at incidences of 1 in 10,000 to 1 in 100,000 shows why standard trials cannot surface these reactions, so their absence from pre-approval data is no reassurance.

Manages Complexity

The unexpected-drug-effect space looks like a scatter of unrelated rare catastrophes, each its own investigation. The category compresses that scatter into one mechanism class read through three features in sequence: dose-independent, qualitatively different in kind, confined to a small fraction under uniform exposure. You track one regularity — uniform exposure meeting a biologically-defined susceptible tail — instead of each harm alone.

Abstract Reasoning

The master move is a three-feature causal classification, refusing to read the event as a mere outlier. That typing blocks the wrong inference that dose reduction will help. An epidemiological boundary-drawing move infers trial-invisibility from incidence and cohort size, and an interventionist-with-foresight move converts the unpredictable into the preventable by finding a responder variant to screen.

Knowledge Transfer

Within pharmacology and toxicology the concept transfers as mechanism, carrying its full diagnostic and preventive apparatus across drug classes via shared templates (reactive-metabolite-plus-HLA, immune hapten, mitochondrial sensitivity). Beyond pharmacology the honest verdict is shared abstract mechanism, not transfer of the named concept: the recurring pattern is uniform exposure meeting a heterogeneous tail that pre-deployment testing is underpowered to detect. That lesson generalizes through the parent primes tail_risk, heterogeneity, and surveillance, not the clinical label.

Relationships to Other Abstractions

Current abstraction Idiosyncratic Reaction Domain-specific

Parents (2) — more general patterns this builds on

• Idiosyncratic Reaction is a kind of Adverse Drug Reaction Domain-specific

  Idiosyncratic Reaction is the Type-B Adverse Drug Reaction specialized by dose independence, qualitative novelty, and a rare susceptible subgroup.

• Idiosyncratic Reaction is a decomposition of Distributional Effects Prime

  Removing clinical vocabulary leaves one intervention producing structurally heterogeneous unit effects concealed by an aggregate or average response.

Hierarchy paths (8) — routes to 7 parentless roots

• Idiosyncratic Reaction → Adverse Drug Reaction → Adverse Drug Event → Adverse Event

Show alternative paths (7)

Neighborhood in Abstraction Space

Idiosyncratic Reaction sits in a sparse region of the domain-specific corpus (67^th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.

Family — Pharmacokinetics & Drug Response (19 abstractions)

Nearest neighbors

• Adverse Drug Event — 0.85
• Adverse Drug Reaction — 0.84
• Polypharmacy — 0.83
• Therapeutic Duplication — 0.83
• Pharmacodynamic Antagonism — 0.83

Computed from structural-signature embeddings · 2026-07-12